Clinical Trial Update: NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy [Phase 2]

View source ↗

Summary

NoNO Inc. reports that the NoNO-42 Phase 2 trial for acute ischemic stroke patients eligible for thrombolysis with or without endovascular thrombectomy is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• NoNO-42

Snippet

Sponsor: NoNO Inc. | Conditions: Acute Ischemic Stroke | Phase 2 | Status: RECRUITING